Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Hereditary multiple exostoses (HME) is a rare genetic disorder characterized by the development of multiple benign bone tumors, known as osteochondromas, which typically grow near the growth plates of long bones. These growths can cause skeletal deformities, pain, and restricted movement, and they require long-term orthopedic monitoring to manage potential complications. What is Hereditary multiple exostoses and how does it affect the body? Hereditary multiple exostoses (HME) is a condition where the body develops multiple bony outgrowths capped with cartilage, called osteochondromas.
1 people with Hereditary multiple exostoses have shared their first-person experience on this question at DiseaseMaps.
TL;DR: Hereditary multiple exostoses (HME) is a rare genetic disorder characterized by the development of multiple benign bone tumors, known as osteochondromas, which typically grow near the growth plates of long bones. These growths can cause skeletal deformities, pain, and restricted movement, and they require long-term orthopedic monitoring to manage potential complications.
Hereditary multiple exostoses (HME) is a condition where the body develops multiple bony outgrowths capped with cartilage, called osteochondromas. These tumors most frequently occur in the long bones of the arms and legs, such as near the knees, ankles, wrists, and shoulders. Because these growths occur near the growth plates, they can interfere with normal bone development, leading to limb length discrepancies, bowed legs, or restricted joint mobility. While these tumors are almost always benign, their presence can cause pressure on surrounding nerves, blood vessels, or tendons, leading to chronic pain or numbness. Within the Hereditary multiple exostoses community at DiseaseMaps.org, 266 members have shared their experiences, highlighting how varied the impact can be from person to person.
Hereditary multiple exostoses is primarily caused by mutations in the EXT1 or EXT2 genes. These genes provide instructions for producing proteins that help build heparan sulfate, a complex molecule essential for proper bone growth and cartilage development. When these genes are mutated, the signaling process that tells bone cells when to stop growing is disrupted, leading to the formation of the characteristic bony bumps. Because this is a genetic condition, it follows an autosomal dominant inheritance pattern, meaning an individual only needs one copy of the mutated gene from one parent to develop the disorder.
Hereditary multiple exostoses is a rare condition with an estimated prevalence of approximately 1 in 50,000 individuals worldwide. While both males and females are affected, clinical reports suggest that males may experience more severe skeletal symptoms. The condition is usually diagnosed in early childhood, with the vast majority of patients showing clinical signs by the age of 12. Because Hereditary multiple exostoses is hereditary, family history is a key factor in identifying at-risk children shortly after birth.
It is important to differentiate Hereditary multiple exostoses from solitary osteochondromas, which are much more common and do not have a genetic, hereditary basis. Key clinical features include:
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding any medical condition.